Nuvation Bio Inc. short interest in 2024
In 2024, Nuvation Bio Inc.'s disclosed short interest ran from 1.03% of shares outstanding on 12 Jan 2024 to 6.22% on 31 Dec 2024, a change of +5.19 percentage points. The year's high was 8.60% on 30 Sep 2024 and its low 1.03% on 12 Jan 2024, averaging 3.84% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.39 days on 13 Sep 2024. Full history: Nuvation Bio Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 1.03% (12 Jan 2024)
- End of year
- 6.22% (31 Dec 2024)
- Change
- +5.19 pp
- High
- 8.60% (30 Sep 2024)
- Low
- 1.03% (12 Jan 2024)
- Average
- 3.84%
- Highest days to cover
- 13.39 (13 Sep 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 1.03% | 3.11 | |
| 31 Jan 2024 | 1.41% | 4.82 | |
| 15 Feb 2024 | 1.19% | 5.27 | |
| 29 Feb 2024 | 1.21% | 3.87 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 1.29% | 2.99 | |
| 28 Mar 2024 | 1.37% | 1.00 | |
| 15 Apr 2024 | 1.46% | 2.18 | |
| 30 Apr 2024 | 1.37% | 2.98 | |
| 15 May 2024 | 1.34% | 2.55 | 10-Q filed, results (8-K) |
| 31 May 2024 | 2.48% | 4.33 | |
| 14 Jun 2024 | 4.70% | 7.91 | |
| 28 Jun 2024 | 5.03% | 4.66 | |
| 15 Jul 2024 | 5.78% | 8.37 | |
| 31 Jul 2024 | 6.31% | 11.09 | |
| 15 Aug 2024 | 6.62% | 10.98 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 7.21% | 13.34 | |
| 13 Sep 2024 | 8.12% | 13.39 | |
| 30 Sep 2024 | 8.60% | 11.56 | |
| 15 Oct 2024 | 4.00% | 6.27 | |
| 31 Oct 2024 | 3.36% | 7.87 | |
| 15 Nov 2024 | 3.26% | 4.28 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 4.18% | 5.29 | |
| 13 Dec 2024 | 4.58% | 7.91 | |
| 31 Dec 2024 | 6.22% | 7.77 |
See also: Nuvation Bio Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.